Published:  Jul 30, 2018DOI: 10.7324/JAPS.2018.8715
A simple and selective reversed phase HPLC-UV method for rifampicin and isoniazid quantification in human plasma was developed and validated. The method consisted of drug extraction with trichloroacetic acid and organic solvent followed by derivatization of isoniazid. Using an isocratic mode, rifampicin was analyzed on a C18 (250 × 4.6 mm, 5 μm) column at 339 nm, while isoniazid was analyzed on a C8 (250 × 4.6 mm, 5 μm) column at 273 nm. All validation parameters fulfilled the FDA requirements, as the method was accurate (bias% < 10.26), precise (CV% < 10.39) and linear from 0.31 to 37.80 μg/mL of rifampicin and 0.89 to 71.36 μg/mL of isoniazid. The samples remained stable during the usual processing and analysis times and also during the two freeze/thaw cycles. The recovery of both analytes was reproducible (CV% < 11.2) in the range of 97.3-99.6% of rifampicin and 89.8-96.6% of isoniazid. The low volume of plasma necessary for the quantification of the samples (750 μL in total) and the low limit of quantification (0.31 μg/mL for rifampicin and 0.89 μg/mL for isoniazid) made this method useful for carrying out pharmacokinetic tests both in humans or animal models. In addition, the method can be successfully applied for bioavailability studies or drug monitoring in tuberculosis treatment.
Luciani-Giacobbe LC, Guzman ML, Manzo RH, Olivera ME. Validation of a simple isocratic HPLC-UV method for rifampicin and isoniazid quantification in human plasma. J App Pharm Sci, 2018; 8(07): 093-099.
495 Absract views 20 PDF Downloads 515 Total views
Pharmacokinetic concerns in the management of drug induced vomiting in co-morbid tuberculosis patient: A case report from MalaysiaAtif M, Sulaiman SAS, Shafie AA, Muttalif AR4, Ali I, Saleem F
Antituberculotic Chemotherapy-General and Hepatic Toxicity Revisited
Rapid high Performance liquid Chromatography- Tandem mass Spectrometry Method For Quantitation of Milnacepran in Human Plasma
Development and validation of dissolution proceduresBhavesh Vaghela, Rajan Kayastha, Nayana Bhatt, Nimish Pathak, Dashrath Rathod
Synthesis and screening of new maleimide derivatives as potential anti-tubercular agents